Conatus Pharmaceuticals (CNAT) null Earnings

12MarConfirmed
May 14
Aug 14
Nov 14
Mar 15
-0.42
-0.39
-0.37
-0.34

Details

Expected EPS
N/A
Actual EPS
-0.3432
Surprise EPS
-0.34
Surprise Percent
+∞%

Description

Conatus Pharmaceuticals (CNAT) has reported earnings of -0.3432 per share for .

0 Comments

Share your thoughts